Two More Devices Qualify For New Technology Add-On Payments – IPPS Rule
This article was originally published in The Gray Sheet
Executive Summary
Medtronic remains the only device firm to qualify for CMS' elusive new technology add-on payments, with three out of its four applications accepted
You may also be interested in...
New Tech Add-On Payments: Plan Early, Meet Often With CMS – Kuhn, Farkas
Early and frequent communication with CMS will enhance new technology add-on payment applicants' prospects for success, according to Center for Medicare Management Director Herb Kuhn
New Tech Add-On Payments: Plan Early, Meet Often With CMS – Kuhn, Farkas
Early and frequent communication with CMS will enhance new technology add-on payment applicants' prospects for success, according to Center for Medicare Management Director Herb Kuhn
AdvaMed To Seek Legislative Fix To Ease New Tech Add-On Payment Criteria
CMS' discovery that Stryker Biotech (OP-1) has offered a comparable product to Medtronic's InFuse bone graft for tibia fractures since 2001 led the agency to reject the latter firm's new technology add-on application